Emerging Infectious Diseases (Feb 2021)

Plasmodium ovale wallikeri and P. ovale curtisi Infections and Diagnostic Approaches to Imported Malaria, France, 2013–2018

  • Valentin Joste,
  • Justine Bailly,
  • Véronique Hubert,
  • Cécile Pauc,
  • Mathieu Gendrot,
  • Emilie Guillochon,
  • Marylin Madamet,
  • Marc Thellier,
  • Eric Kendjo,
  • Nicolas Argy,
  • Bruno Pradines,
  • Sandrine Houzé

DOI
https://doi.org/10.3201/eid2702.202143
Journal volume & issue
Vol. 27, no. 2
pp. 372 – 384

Abstract

Read online

We retrospectively analyzed epidemiologic, clinical, and biologic characteristics of 368 Plasmodium ovale wallikeri and 309 P. ovale curtisi infections treated in France during January 2013–December 2018. P. ovale wallikeri infections displayed deeper thrombocytopenia and shorter latency periods. Despite similar clinical manifestations, P. ovale wallikeri–infected patients were more frequently treated with artemisinin-based combination therapy. Although the difference was not statistically significant, P. ovale wallikeri–infected patients were 5 times more frequently hospitalized in intensive care or intermediate care and had a higher proportion of severe thrombocytopenia than P. ovale curtisi–infected patients. Rapid diagnostic tests that detect aldolase were more efficient than those detecting Plasmodium lactate dehydrogenase. Sequence analysis of the potra gene from 90 P. ovale isolates reveals an insufficient polymorphism for relapse typing.

Keywords